BDSI, AZZ, GBX - CRWESelect.com Stock News! BioDelivery Sciences International, AZZ Incorporated, Greenbrier Companies (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) January 6, 2012 -- To view video, and read the full article visit URL http://crweselect.com/28072/stock-alerts/bdsi-azz-gbx-crweselectcom-stock-news-biodelivery-sciences-international-azz-incorporated-greenbrier-companies-video-included-inside/

BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

BDSI announced today the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain. BEMA Buprenorphine utilizes BDSI's patented and proven BioErodible MucoAdhesive (BEMA) technology to deliver the opioid analgesic buprenorphine.

BDSI is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and oncology supportive care. BDSI's pain franchise currently consists of two products utilizing the patented BEMA technology. ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada , and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer. The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.). BDSI's second pain product, BEMA Buprenorphine, is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation with naloxone for the treatment of opioid dependence. BEMA Buprenorphine for chronic pain is licensed on a worldwide basis to Endo Pharmaceuticals. Additional product candidates are being developed utilizing the BEMA technology for conditions such as nausea/vomiting (BEMA Granisetron). BDSI's headquarters is located in Raleigh , North Carolina.

For more information about BDSI please visit http://www.bdsi.com/

****

AZZ Incorporated (NYSE:AZZ)

AZZ announced today unaudited financial results for the three and nine-month periods ended November 30, 2011 . Revenues for the third quarter were $116.5 million compared to $102.9 million for the same quarter last year, an increase of 13 percent. Net income for the third quarter was $10 million , or $0.79 per diluted share, compared to net income of $9.7 million , or $0.77 per diluted share, in last year's third fiscal quarter.

AZZ is a specialty electrical equipment manufacturer serving the global markets of power generation, transmission and distribution and industrial, as well as a leading provider of hot dip galvanizing services to the steel fabrication market nationwide.

For more information about AZZ please visit http://www.azz.com

****

Greenbrier Companies, Inc. (NYSE:GBX)

GBX reported today results for its fiscal first quarter ended November 30, 2011. Revenues for the first quarter of 2012 were $398.2 million , double the $198.9 million realized in the prior year's first quarter.

GBX, headquartered in Lake Oswego, Oregon , is a leading supplier of transportation equipment and services to the railroad industry. Greenbrier builds new railroad freight cars in its three manufacturing facilities in the U.S. and Mexico and marine barges at its U.S. facility. It also repairs and refurbishes freight cars and provides wheels and railcar parts at 38 locations across North America . Greenbrier builds new railroad freight cars and refurbishes freight cars for the European market through both its operations in Poland and various subcontractor facilities throughout Europe . Greenbrier owns approximately 9,000 railcars, and performs management services for approximately 217,000 railcars.

For more information about GBX please visit http://www.gbrx.com/

To read the full article visit URL http://crweselect.com/28072/stock-alerts/bdsi-azz-gbx-crweselectcom-stock-news-biodelivery-sciences-international-azz-incorporated-greenbrier-companies-video-included-inside/

******************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

BDSIcrweselect0106
AZZcrweselect0106
GBXcrweselect0106

AZZ     AZZ Incorporated     BDSI     BEMA Buprenorphine     BioDelivery Sciences Int.     Endo Pharmaceuticals     GBX     Greenbrier Companies